BIOFILM FORMATION BY UROPATHOGENIC ESCHERICHIA COLI AND ITS ANTIBIOTIC RESISTANCE PATTERN IN TERTIARY CARE CENTRE

Aravindhan. G, Dr. S. S. M. Umamageswari, M. Mohana Priya

Abstract


Urinary tract  infections (UTI) is a serious health problem with respect to antibiotic resistance and biofilm formation being the prime cause for antibiotic resistance. The biofilms produced by E.coli may be difficult to treat as they exhibit multidrug resistance. The present study is aimed to perform invitro detection of biofilm formation among E.coli strains from urine cultures. A total number of 180 E.coli strains were isolated from urine samples suffering from UTI. The samples were processed using standard phenotypic identification  techniques and tested for biofilm production by three methods congo red agar(CRA), tube method(TM) and tissue culture plate method(TCP). Among 180 E.coli isolates, 80 and 100 strains were collected from catheterized and non-catheterized patients respectively. In biofilm production 96, 97 and 119 were positive for biofilm productions by Congo red agar (CRA), Tube method(TM) and Tissue culture plate (TCP) method respectively. Among the biofilm producers maximum resistance was seen to cephalexin 168(93%), ampicillin 158(87%), norfloxacin 154(85%), ciprofloxacin154(85%),ceftazidime with clavulinic acid 146 (81%),gentamicin125(69%), piperacillin tazobactam 81(45%), cefoperazone  with sulbactam 79(43%). The antibiotic resistance among biofilm producing E.coli was found to be higher than that of non-biofilm with a p=0.01(<0.05)which is statistically significant. A greater understanding of the nature of biofilm  producing  E.coli in UTIs will help in the development of new and more effective treatment.   


Keywords


Escherichia coli, antibiotic resistance, biofilm.

Full Text:

PDF

References


Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol 2004;2:123‑40.

Warren JW, Tenney JH, Hoopes JM, Muncie HL, Anthony WC. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis 1982;146:719‑23.

Stamm WE. Catheter‑associated urinary tract infections: Epidemiology, pathogenesis, and prevention. Am J Med 1991;91:65S‑71S.

Sevanan M, Pongiya U, Peedikavil NJ. Antimicrobial susceptibility pattern of biofilm producing Escherichia coli of urinary tract infections. Curr Res Bacteriol 2011;4:73‑80.

Saroj G, Vivek H, Sujata KK, Reddy M. Correlation between biofilm formation of uropathogenic Escherichia coli and its antibiotic resistance pattern. J Evol Med Dent Sci 2012;1:166‑75.

Sharma M, Aparna, Yadav S, Chaudhary U. Biofilm production in uropathogenic Escherichia coli. Indian J Pathol Microbiol 2009;52:294.

Soto SM, Smithson A, Horcajada JP, Martinez JA, Mensa JP, Vila J, et al. Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli. Clin Microbiol Infect 2006;12:1034‑6.

González MJ, Robino L, Iribarnegaray V, Zunino P, Scavone P. Effect of different antibiotics on biofilm produced by uropathogenic Escherichia coli isolated from children with urinary tract infection. Pathog Dis 2017;75: 1‑9.

Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 2001;358:135‑8.

Panda PS, Chaudhary U, Dube SK. Comparison of four different methods for detection of biofilm formation by uropathogens. Indian J Pathol Microbiol 2016;59:177‑9.

Rashmi MK, Mahantesh BN. Characterization and antibiotic susceptibility pattern of coagulase negative staphylococci with special reference to methicillin resistance. Int J Curr Microbiol App Sci 2016;5:114‑20.

Ponnusamy P, Natarajan V, Sevanan M. In vitro biofilm formation by uropathogenic Escherichia coli and their antimicrobial susceptibility pattern. Asian Pac J Trop Med 2012;5:210‑3.

Suman E, Jose J, Varghese S, Kotian MS. Study of biofilm production in Escherichia coli causing urinary tract infection. Indian J Med Microbiol 2007;25:305‑6.

Mittal S, Sharma M, Chaudhary U. Biofilm and multidrug resistance in uropathogenic Escherichia coli. Pathog Glob Health 2015;109:26‑9.


Refbacks

  • There are currently no refbacks.